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Summary
Background—Malaria is a major cause of morbidity and mortality in early childhood, yet its
consequences for health and education during the school-age years remain poorly understood. We
examined the effect of intermittent preventive treatment (IPT) in reducing anaemia and improving
classroom attention and educational achievement in semi-immune schoolchildren in an area of
high perennial transmission.
Methods—A stratified, cluster-randomised, double-blind, placebo-controlled trial of IPT was
done in 30 primary schools in western Kenya. Schools were randomly assigned to treatment
(sulfadoxine-pyrimethamine in combination with amodiaquine or dual placebo) by use of a
computer-generated list. Children aged 5–18 years received three treatments at 4-month intervals
(IPT n=3535, placebo n=3223). The primary endpoint was the prevalence of anaemia, defined as a
haemoglobin concentration below 110 g/L. This outcome was assessed through cross-sectional
surveys 12 months post-intervention. Analysis was by both intention to treat, excluding children
with missing data, and per protocol. This study is registered with ClinicalTrials.gov, number
NCT00142246.
Findings—2604 children in the IPT group and 2302 in the placebo group were included in the
intention-to-treat analysis of the primary outcome; the main reason for exclusion was loss to
follow-up. Prevalence of anaemia at 12 months averaged 6·3% in the IPT group and 12·6% in the
placebo group (adjusted risk ratio 0·52, 95% CI 0·29–0·93; p=0·028). Significant improvements
were also seen in two of the class-based tests of sustained attention, with a mean increase in code
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transmission test score of 6·05 (95% CI 2·83–9·27; p=0·0007) and counting sounds test score of
1·80 (0·19–3·41; p=0·03), compared with controls. No effect was shown for inattentive or
hyperactive-compulsive behaviours or on educational achievement. The per-protocol analysis
yielded similar results. 23 serious adverse events were reported within 28 days of any treatment
(19 in the IPT group and four in the placebo group); the main side-effects were problems of
balance, dizziness, feeling faint, nausea, and/or vomiting shortly after treatment.
Interpretation—IPT of malaria improves the health and cognitive ability of semi-immune
schoolchildren. Effective malaria interventions could be a valuable addition to school health
programmes.
Funding—Gates Malaria Partnership, the Norwegian Education Trust Fund and multidonor
Education Development Programme Fund of the World Bank, DBL Centre for Health Research
and Development, and the Wellcome Trust.
Introduction
Children living in areas of high malaria transmission rapidly acquire immunity to malaria in
early childhood; by the time they reach school age, the risk of clinical attacks and death has
reduced. However, many school-aged children continue to harbour asymptomatic
parasitaemia, which can cause anaemia. Although malaria might have an adverse effect on
cognition and education outcomes, evidence for this has so far been lacking, and the case for
school-based malaria control has not been established. Historically, malaria
chemoprophylaxis given to African schoolchildren was associated with lower rates of
malaria parasitaemia and severe anaemia, fewer clinical attacks and malaria deaths, and
reduced school absenteeism because of malaria. One randomised trial has investigated the
effect of clinical malaria on educational outcomes and provides evidence that school
performance is related to the cumulative effect of previous malaria attacks and that weekly
chemoprophylaxis with chloroquine can improve school examination scores in Sri Lankan
children. However, this approach faces operational challenges, and could prove less
effective in sub-Saharan Africa, where subclinical infections predominate. An alternative
strategy is intermittent preventive treatment (IPT), which involves the periodic mass
administration of a full therapeutic course of an antimalarial drug, irrespective of infection
status. We undertook a randomised controlled trial in western Kenya to investigate the
efficacy of school-based IPT in reducing anaemia and improving classroom attention and
educational achievement.
Methods
Participants
This stratified, cluster-randomised, double-blind, placebo-controlled trial was done between
March, 2005, and March, 2006, in primary schools in Bondo district, western Kenya.
Malaria transmission is intense and perennial in this region, with two seasonal peaks
(March–May and November–December). By school age, clinical incidence declines to 0·25
episodes per child per year, although up to 50% of schoolchildren have asymptomatic
malaria parasitaemia.
Rural primary schools with 150 children or more, and over 15 children per class were
eligible for inclusion. Schools located within 5 km from Lake Victoria were excluded to
minimise confounding by Schistosoma mansoni. Meetings were held in participating schools
to explain the nature and purpose of the trial to parents or legal guardians, and written
informed consent was obtained. Schoolchildren with parental consent and no history of
adverse reaction to sulfa-based drugs were eligible for recruitment. Children with a
Clarke et al. Page 2
Published as: Lancet. 2008 July 12; 372(9633): 127–138.
Sponsored D
ocum
ent 
Sponsored D
ocum
ent 
Sponsored D
ocum
ent
haemoglobin concentration of less than 70 g/L at baseline, or known or suspected to be
homozygous for sickle-cell trait or pregnant were not enrolled.
The protocol was approved by the ethics review boards of Kenyatta National Hospital,
Kenya; London School of Hygiene and Tropical Medicine, UK; and Danish National
Committee on Medical Research Ethics, Denmark. Permissions were obtained from the
Kenyan Ministry of Education, the District Education and Health Authorities, and head
teachers. An independent data safety monitoring board monitored the trial and approved the
analysis plan.
Procedures
We stratified schools into three groups according to school examination performance in
previous years, to account for differences in school quality and socioeconomic environment.
Ten schools were randomly selected from each school-performance stratum, and within each
stratum schools were randomly allocated to one of six coded drug groups by use of block
randomisation (three pairs of either active drugs or dual placebo) according to a computer-
generated random number list by an investigator (SEC) blind to drug group.
Children in intervention schools received IPT with one dose of sulfadoxine-pyrimethamine
and three daily doses of amodiaquine on three occasions within a 12-month period (once
each school term). IPT was first given in May, 2005, coinciding with a seasonal peak in
transmission, and then repeated in September, 2005, and January, 2006. Children absent
from school were not treated. Children in control schools received dual placebo tablets over
3 consecutive days on each occasion.
Study drugs and placebos were manufactured by Cosmos Limited (Nairobi, Kenya) and
labelled according to six coded drug groups. The code was held by the manufacturers and
the data safety monitoring board, and revealed to the investigators only after completion of
the statistical analysis. Dosage was by age. Participants were observed for 30 min after drug
intake and treatment re-administered once more if spitting or vomiting occurred. Active
drugs and placebos were similar in size and shape, but differed in taste. To preserve
blinding, staff responsible for measuring health or education outcomes were unaware of
drug group allocation, and analysis was done by a statistician with no previous involvement
in the trial. Adverse events were monitored by the study team for 3 days after each
treatment, and a further 28 days thereafter using a passive surveillance system in schools and
local health centres. Travel costs were reimbursed and treatment charges waived. Adverse
effects were monitored until the event was cured or had stabilised.
Incidence of clinical attacks was not measured, although a blood slide was prepared in
children presenting with fever during school visits, and slide-positive cases were treated for
malaria in accordance with national guidelines. Children with a haemoglobin concentration
less than 70 g/L were given a course of haematinics. S mansoni-positive children received
one dose of praziquantel (40 mg/kg). Children in all schools (intervention and placebo)
received mass treatment twice a year for soil-transmitted helminth infections with one dose
of albendazole (400 mg).
We investigated whether intermittent clearance of malaria parasitaemia would increase
haemoglobin concentrations and, as a consequence, reduce anaemia and contribute to
improved attention in class and educational performance. The primary endpoint was the
prevalence of anaemia, defined as a haemoglobin concentration of less than 110 g/L, after
12 months of intervention. Secondary endpoints included prevalence and intensity of
Plasmodium falciparum infection, mean haemoglobin concentration, sustained attention, and
educational achievement.
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Cross-sectional surveys were done in all schools in March, 2006, approximately 6 weeks
after the last treatment. Finger-prick blood samples were obtained from all children with
consent (aged 5–18 years) to assess haemoglobin concentration with a portable photometer
(Hemocue, Angelholm, Sweden). Blood slides prepared for malaria were declared negative
only after examination of 100 high-powered fields. Data on covariates, including bednet use
and household socioeconomic status were obtained through a questionnaire administered to
children in classes 2–7 (aged 7–17 years) during the final survey. Height and weight were
measured, and anthropometric indices calculated. For logistical reasons, only children in
classes 5 and 6 were asked to provide stool samples, which were examined microscopically
for helminth eggs by use of the Kato-Katz technique.
The effect of the intervention on cognitive abilities was investigated primarily by comparing
differences in test scores of sustained attention given to a cohort of children in classes 5 and
6 (aged 11–16 years). This group was selected for testing because they were old enough to
understand the test instructions. Secondary education outcomes included behaviour in class
and educational achievement.
Two tests of sustained attention were undertaken on the day preceding health assessments.
Both tests were adapted from the TEA-Ch (tests of everyday attention for children) battery
for group administration in groups of 15 or fewer, and given by a psychologist already
trained in doing these tests. The tests involved listening to a tape and identifying different
sounds (counting sounds) and numbers (code transmission). In the counting sounds tasks
children were required to count a series of electronic beeps played on the tape recorder, with
varying delays of 0·3–10 seconds between sounds. Sustained attention was required to keep
track of the number of sounds counted during delays and to be prepared for bursts of several
consecutive sounds. In the code transmission tasks, a list of digits was read out aloud at the
speed of one per second. Children were required to listen out for a “code”—two consecutive
occurrences of the number 5—and then record the two numbers that preceded the code. A
second test, included in the final survey, required children to recall the three numbers that
preceded the code. Before each test children were given a warm-up activity to familiarise
them with the tape recorder, and three practice exercises. Internal reliability was high for
both tests (Cronbach α>0·7 for counting sounds and α>0·8 for code transmission).
Classroom behaviour was assessed by teacher ratings of inattentive and hyperactive-
impulsive behaviours in eight children randomly selected (by MCHJ) from each class by use
of a computer-generated random number list. Behaviours were selected from the early
childhood attention deficit disorder scale. Behaviours that were weakly correlated (<0·3)
with the sum of other behaviour scores in piloting were deemed not to be strongly related to
the overall trait and were dropped from the final instrument. Internal reliability was high
(Cronbach α>0·8). Assessment of educational achievement focused on learning which
occurred towards the end of the intervention year, when the cumulative effect of repeated
malaria treatment should have achieved maximum improvements in classroom attention.
Knowledge of a content-based subject, taught during the last school term of the study, was
measured in the two intervention groups. In January, 2006, teachers attended a 1-day
training seminar to standardise the curriculum and teaching methods for social studies in
classes 6 and 7. Children were tested at the end of the school term. A multiple choice exam
was developed for each class. Internal reliability was adequate for both class exams
(Cronbach α=0·62 for class 6 and α=0·59 for class 7).
Statistical analysis
On the basis of an observed anaemia prevalence of 38% at baseline and coefficient of
variation between clusters of 0·27, a sample size of 12 schools with a total of 889 children in
each arm was estimated to provide 80% power to detect a 30% reduction in the prevalence
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of anaemia in the intervention group compared with placebo at 5% level of significance. For
the cognitive and education tests, where an intraclass correlation of 0·20 was assumed, a
minimum of 15 schools per arm with 60 children assessed per school were needed to
provide 80% power to detect an effect size of 0·25 in the intervention group compared with
placebo at 5% level of significance.
Data were analysed by intention to treat, excluding those children with missing data. A per-
protocol analysis was also done, including only children treated on all three rounds and who
completed the full 3-day regimen on each occasion, totalling 9 days of treatment. Children
who received either haematinics for severe anaemia or active antimalarials for clinical
malaria, or both, at any point during the study were excluded from the per-protocol analysis.
The effect of the intervention was analysed with methods appropriate for a cluster-
randomised trial. The prevalence, or mean, in each school was calculated and the unadjusted
risk ratio, or mean difference (intervention–control), estimated in each stratum. An overall
estimate of the effect of IPT was obtained by taking a weighted average of the stratum-
specific estimates, the weights proportional to the number of schools per stratum, and 95%
CIs were adjusted for observed between-school variance (Hayes R, London School of
Hygiene and Tropical Medicine, personal communication). Effect size for cognition was
calculated by dividing the difference in the mean cluster-level summaries by the standard
deviation of individual values averaged across study arms. Formal hypothesis testing was
done with stratified unpaired t tests. Standard individual-level regression analysis, which
incorporated stratum as a fixed effect and all covariates, suspected a priori to be confounders
or effect modifiers, except the intervention effect, was used to calculate cluster-level
expected values. Observed and expected values were compared by computing a residual,
based on the ratio of observed to expected or the difference between observed and expected,
for each school. Adjustment for covariates was undertaken replacing school-level means and
proportions with covariate-adjusted residuals. Additionally, the effect of intervention was
assessed with adjustment for baseline characteristics among those children for whom
baseline data were available. All analyses were undertaken using STATA version 9.2.
This study is registered with ClinicalTrials.gov, number NCT00142246.
Role of the funding source
The sponsor of the study had no role in study design, data collection, analysis, interpretation,
or writing of the report. SEC, MCHJ, BC, and SB had full access to the data and made the
final decision to submit for publication.
Results
The trial profile is shown in figure 1. 4916 (73%) of 6758 school children enrolled in the
trial were examined in the post-intervention survey 12 months later. The numbers of
children lost to follow-up were similar in IPT intervention and placebo schools (26% and
28%, respectively). Health outcomes for children in the intervention group (n=2611) and
placebo group (n=2305) were analysed according to intention to treat. Most children
examined post-intervention had received treatment on all three occasions (more than 7 days
of treatment were completed by 1946 [75%] and 1990 [86%] in each group), although only
1070 (41%) of children in the intervention group and 1394 (60%) in the placebo group had
received treatment on all 9 days and were included in the per-protocol analysis of health
outcomes. Children lost to follow-up and those who received incomplete treatment had
similar baseline characteristics to children included in the per-protocol analysis (table 1 and
table 2). Children in the IPT intervention and placebo groups were similar, although those in
the IPT intervention group had slightly better nutritional status at baseline and fewer
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children were anaemic. Imbalances in helminth infection at baseline were successfully
corrected with anthelmintic mass treatment and no marked differences in prevalence of
helminth infections existed between intervention and placebo groups at follow-up. 818
children (76% of the original education cohort in classes 5 and 6 at baseline) participated in
the tests of sustained attention post-intervention (436 in the IPT group, 382 in the placebo
group). Children lost to follow-up were similar to those examined post-intervention (data not
shown). Study endpoints and nutritional status in the IPT and placebo groups were similar at
baseline, with slight differences in socioeconomic background (table 2 and table 3).
At follow-up, the prevalence of anaemia among schoolchildren in the IPT intervention group
was significantly lower than in the placebo group (table 4). Results of the intention-to-treat
analysis show that the protective efficacy of the intervention against anaemia was 48% (95%
CI 8–71; p=0·028; table 4). The adjusted risk difference was −0·06 (−0·01 to −0·11),
equating to one case of anaemia prevented for every 16 children treated with IPT (95% CI
9–91 children). There were also fewer cases of severe anaemia (haemoglobin <70 g/L) in the
IPT intervention group than in the placebo group (four and 16 cases, respectively).
Similarly, post-intervention mean haemoglobin concentration was significantly higher
among children in the intervention group than among controls (table 4); adjusted difference
5·01 g/L (95% CI 1·62–8·41; p=0·005). IPT seemed to benefit children across the whole
distribution of haemoglobin concentrations, as shown by the different distributions between
the two groups (figure 2). Prevalence of P falciparum parasitaemia was lower among
children receiving IPT than in those in the placebo group, with a protective efficacy against
P falciparum infection of 89% (95% CI 73–95; p=0·0002; table 4). The adjusted risk
difference was −0·35 (0·30 to −0·41), equating to an average of one infection prevented for
every three children treated with IPT (95% CI 2–4 children). Among the subset of children
infected with P falciparum at follow-up, mean parasite density was similar in the two groups
(p=0·108).
Results of the per-protocol analysis, which included only children who received complete
treatment during each treatment round, were similar to those of the intention-to-treat
analysis (table 4). Analysis was also repeated on the subgroup of 2471 children for whom
haemoglobin data at baseline were available, and yielded similar results (data not shown),
confirming that the observed differences are not attributable to slight baseline imbalances in
nutritional status. Although no formal test of interaction was made, we also undertook
prespecified exploratory analyses to investigate the effect of intervention stratified by age,
sex, and anaemia status at baseline. The effect of IPT on anaemia did not differ by age-
group (data not shown), but the effect in girls was slightly greater than in boys (data not
shown). An increase in mean haemoglobin was seen in all subgroups of children, including
those who were not anaemic at baseline (adjusted difference 7·42 g/L, 95% CI 3·05–11·79;
p=0·0018).
At follow-up, scores for sustained attention were higher in the IPT intervention group than
among controls for the counting sounds test (adjusted mean difference 1·80 [0·19–3·41;
p=0·03; table 5) and the code transmission test (adjusted mean difference 6·05 [2·83–9·27];
p=0·0007). The effect size was 1·22 (95% CI 0·003–0·35) in the counting sounds test and
0·86 (0·09–0·88) in the code transmission test. There was no difference in mean score for
inattentive or hyperactive-compulsive behaviours (table 5) or mean educational achievement
test scores (table 6) between study groups.
Seven children died during the 12-month intervention period: two in the IPT intervention
group and five in the placebo group. Cause of death was investigated, but could not be
reliably ascertained in all cases. 23 serious adverse events were reported within 28 days after
any mass treatment (includes children admitted for observation): 19 in the intervention
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group (of which three were judged to be possibly associated with treatment) and four in the
control group. The most common serious adverse events were problems of balance,
dizziness, feeling faint, nausea, or vomiting, which all occurred within 5 h of treatment.
There was only one report of a severe skin reaction, which occurred in the placebo group. A
further 13 adverse events were graded as moderate: six in the intervention group and seven
in the placebo group. Mild events, such as nausea, headache, and prurititis, were more
frequent among children receiving active drugs than among controls (49 and 33 reports,
respectively).
Discussion
This trial has shown that school-based delivery of IPT once per term markedly reduced the
prevalence of anaemia and asymptomatic parasitaemia in semi-immune schoolchildren in
Kenya. We also show a beneficial effect of malaria treatment on sustained attention of
schoolchildren. Although only 73% of enrolled children were followed up, there were no
marked differences in background characteristics or follow-up rates between study groups,
suggesting that treatment effects were not caused by sample bias. Children receiving IPT
were less likely to complete the full 3-day regimen, possibly because of the bitter taste of
amodiaquine, but there was little evidence that this introduced bias since the characteristics
of children who received complete and incomplete treatment were similar. Additionally,
twice yearly anthelmintic treatment was given to all children (intervention and control),
reducing helminth infection and anaemia in both groups from initial baseline levels. The
resultant similarities in levels of helminth infection between study groups at follow-up, as
well as nutritional status, provide convincing evidence that the effect on anaemia was
mainly caused by reductions in malaria parasitaemia.
Our findings are consistent with earlier observations that insecticide-treated bednet use is
associated with reduced anaemia in adolescent schoolgirls, suggesting that malaria control
could have an important role in preventing anaemia in school-aged children. The size of the
protective effect of IPT against anaemia is markedly greater than the protective effects seen
in previous trials of anthelmintic treatment. The effect is also comparable with, or larger
than, reductions in the rates of anaemia seen following iron supplementation. Notably,
previous trials often report that either young children or anaemic children benefit most from
intervention. However, in our study the protective effect of the intervention against anaemia
did not differ among age-groups, and significant improvements in mean haemoglobin
concentrations were seen in children who were not classified as anaemic at baseline. This
effect could have been achieved through the clearance of asymptomatic infections that
would otherwise go untreated, thereby providing a window for haematological recovery.
Decreased rates of destruction and removal of parasitised red blood cells, and improvements
in the rate of erythrocyte production in the bone marrow during parasite-free periods might
contribute to improvements in haemoglobin concentration and anaemia. Long-acting drugs,
such as sulfadoxine-pyrimethamine, could also provide a period of prophylaxis immediately
after treatment.
Concerns that chemoprevention might impede the development of antimalarial immunity
and lead to rebound morbidity might be less relevant in the age-group studied here,
especially under intense transmission where early exposure promotes rapid acquisition of
immunity before reaching school age. Treatment at 4-month intervals permits reinfection,
maintaining levels of exposure-dependent immunity. Studies undertaken after completion of
the trial showed the IPT strategy to be well accepted by teachers, parents, and
schoolchildren (data not shown). Few serious adverse events attributable to study
medication were recorded, and most symptoms were mild and self-limiting. Nonetheless,
their occurrence in healthy asymptomatic children is not desirable.
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Malaria early in life has been shown to impair later cognitive performance and clinical
malaria affects school performance. Our results show that asymptomatic infection can also
affect cognitive performance and that treatment against asymptomatic malaria improves
sustained attention. However, by contrast with the Sri Lankan study, we did not find an
improvement in educational achievement. Mean scores were generally low, suggesting that
examined knowledge improved insufficiently in both placebo and intervention groups for a
difference between them to be detected. Other possible reasons include low statistical power
(<20%) because of greater than expected school-level clustering of educational achievement
scores, short duration of follow-up, and the limited number of schoolchildren tested. Clinical
attacks are less common in our population, which might also explain the difference between
this and the Sri Lankan study.
The mechanism for the effect on cognition is not known, but it is possible that raised
haemoglobin concentrations had a role in improving attention. There is strong evidence that
iron-deficiency anaemia leads to impaired cognitive function, although the cognitive effect
of anaemia due to causes other than iron deficiency is less well understood. Among many
school health and nutrition interventions previously assessed, only iron supplementation and
malaria prevention (in Sri Lanka and the current study) have shown substantial
improvements in cognitive function of around 0·5 SD or greater.
This large field trial, using a randomised design, enabled the effect of malaria on sustained
attention to be demonstrated, and provides strong evidence of a link between asymptomatic
malaria and cognition. We did not, however, do an extensive battery of cognitive tests, and
cannot determine whether asymptomatic malaria affects other aspects of cognitive function.
Neither did we examine the effect of clinical attacks or absenteeism on anaemia or cognitive
function. In other settings where the incidence of clinical attacks in schoolchildren is higher,
this could adversely affect school performance and absenteeism. Knowledge of the effect of
malaria on school performance and education is far from complete, but our findings provide
sufficient evidence to indicate that this warrants more attention.
School health programmes provide an effective vehicle to control anaemia and improve
educational outcomes of school-aged children living in developing countries. The
pronounced effects of the IPT intervention on anaemia and malaria parasitaemia, and the
effect on sustained attention, highlight the issue of the continued, and often unrecognised,
malaria burden among school-aged children in Africa and the potential of school-based
programmes for tackling the problem. Our findings also illustrate the possible gains of
integrating malaria control into broader school health programmes. These results now need
to be replicated in different epidemiological settings. Further research is also needed to
investigate the operational feasibility of the approach, and any long-term educational
benefits.
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Figure 1.
Trial profile
ITT=intention-to-treat. PP=per-protocol.
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Figure 2.
Distribution of haemoglobin concentrations among children, according to treatment
(intention-to-treat population)
Individual-level data are presented; distribution does not take into account the clustering of
children within schools.
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Table 1
Characteristics of schoolchildren included in analyses of health outcomes*
Intention-to-treat population Per-protocol population
Placebo IPT Placebo IPT
Number of children included in analysis 2305 2611 1394 1070
Mean age (years) 11·23 (3·09) 11·24 (3·05) 11·51 (2·92) 11·53 (2·85)
Sex (male) 1209/2305 (52%) 1405/2611 (54%) 708/1394 (51%) 559/1070 (52%)
History of residence in a non-malarious area 190/1952 (10%) 167/2221 (8%) 124/1239 (10%) 82/974 (8%)
Reported use of bednet by child 561/1952 (29%) 495/2215 (22%) 346/1239 (28%) 211/970 (22%)
Household ownership of bicycle 1434/1944 (74%) 1616/2222 (73%) 890/1232 (72%) 698/971 (72%)
House structure
Traditional 654/1957 (33%) 745/2231 (33%) 406/1243 (33%) 321/977 (33%)
Semi-permanent 831/1957 (42%) 874/2231 (39%) 529/1243 (43%) 386/977 (40%)
Permanent 472/1957 (24%) 612/2231 (27%) 308/1243 (25%) 270/977 (28%)
Lighting
Tin lamp only 1325/1956 (68%) 1400/2231 (63%) 839/1242 (68%) 624/976 (64%)
Hurricane lamp 577/1956 (29%) 747/2231 (33%) 369/1242 (30%) 308/976 (32%)
Electricity/other 54/1956 (3%) 84/2231 (4%) 34/1242 (3%) 44/976 (5%)
Family status
Lives with guardian 421/1957 (22%) 437/2234 (20%) 260/1243 (21%) 217/977 (22%)
Lives with one parent 371/1957 (19%) 421/2234 (19%) 231/1243 (19%) 159/977 (16%)
Lives with both parents 1165/1957 (60%) 1369/2234 (61%) 752/1243 (60%) 601/977 (62%)
Parental education†
No education 46/657 (7%) 59/711 (8%) 30/449 (7%) 32/346 (9%)
Primary education only 341/657 (52%) 359/711 (50%) 236/449 (53%) 171/346 (49%)
Secondary education 236/657 (36%) 253/711 (36%) 163/449 (36%) 121/346 (35%)
Higher education 34/657 (5%) 40/711 (6%) 20/449 (4%) 22/346 (6%)
Nutritional status at baseline†‡
Weight-for-age Z score −1·62 (1·05) −1·60 (1·11) −1·65 (1·03) −1·54 (1·08)
Height-for-age Z score −1·68 (1·02) −1·68 (1·12) −1·67 (1·02) −1·63 (1·10)
Helminth infection at follow-up§
Hookworm 74/598 (12%) 82/612 (13%) 47/396 (12%) 34/272 (13%)
Ascaris lumbricoides 28/598 (5%) 32/612 (5%) 15/396 (4%) 9/272 (3%)
Trichuris trichiura 32/598 (5%) 52/612 (8%) 18/396 (5%) 23/272 (8%)
Schistosoma mansoni 59/598 (10%) 32/612 (5%) 29/396 (7%) 15/272 (6%)
Study endpoints at baseline†
Number of children examined 1149 1330 748 637
P falciparum prevalence 465/1113 (42%) 524/1284 (41%) 278/728 (38%) 243/612 (40%)
P falciparum intensity per μL among slide-positive:
geometric mean
1028·85 (1·30) 988·88 (1·18) 923·15 (1·26) 961·23 (1·14)
Anaemia prevalence 254/1145 (22%) 246/1326 (19%) 155/745 (21%) 104/636 (16%)
Mean haemoglobin concentration (g/L) 119·50 (15·54) 121·42 (14·47) 119·78 (15·27) 122·19 (14·13)
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Data are mean (SD) or n/N (%) unless specified otherwise.
*
Data obtained at follow-up for all classes (5–18 years), apart from where indicated.
†
Measured at baseline among children who were enrolled in classes 5 and 6; also includes data for children in all classes in a randomly selected
subset of 12 schools.
‡
Anthropometric indices calculated on the basis of the 2000 Centers for Disease Control and Prevention growth charts. Weight-for-height
standards were only available for children up to 121 cm in height and thus not calculated. Measured at baseline (ITT: 1141 placebo, 1321 IPT; PP:
744 placebo, 633 IPT).
§
Helminth infection was only measured among children enrolled in classes 5 and 6 at baseline.
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Table 2
Characteristics of schoolchildren included in analyses of education outcomes*
Intention-to-treat population Per-protocol population
Placebo IPT Placebo IPT
Number of children included in analysis 382 436 274 209
Mean age (years) 13·74 (1·17) 13·89 (1·19) 13·71 (1·18) 13·83 (1·17)
Sex (male) 196/382 (51%) 213/436 (49%) 134/274 (49%) 97/209 (46%)
History of residence in a non-malarious area 40/381 (10%) 47/435 (11%) 26/273 (10%) 25/208 (12%)
Reported use of bednet by child 73/380 (19%) 72/433 (17%) 51/272 (19%) 33/208 (16%)
Household ownership of bicycle 257/380 (68%) 290/433 (67%) 183/272 (67%) 136/208 (65%)
House structure
Traditional 132/382 (35%) 153/435 (35%) 98/274 (36%) 66/208 (32%)
Semi-permanent 164/382 (43%) 151/435 (35%) 113/274 (41%) 74/208 (36%)
Permanent 86/382 (23%) 131/435 (30%) 63/274 (23%) 68/208 (33%)
Lighting
Tin lamp only 268/382 (70%) 267/435 (61%) 193/274 (70%) 125/208 (60%)
Hurricane lamp 107/382 (28%) 152/435 (35%) 76/274 (28%) 72/208 (35%)
Electricity/other 7/382 (2%) 16/435 (4%) 5/274 (2%) 11/208 (5%)
Family status
Lives with guardian 89/382 (23%) 94/433 (22%) 60/274 (22%) 47/207 (23%)
Lives with one parent 74/382 (19%) 93/433 (21%) 53/274 (19%) 39/207 (19%)
Lives with both parents 219/382 (57%) 246/433 (57%) 161/274 (59%) 121/207 (58%)
Parental education†
No education 24/298 (8%) 31/315 (10%) 18/213 (8%) 16/144 (11%)
Primary education only 139/298 (47%) 158/315 (50%) 93/213 (44%) 68/144 (47%)
Secondary education 117/298 (39%) 111/315 (35%) 90/213 (42%) 51/144 (35%)
Higher education 18/298 (6%) 15/315 (5%) 12/213 (6%) 9/144 (6%)
Nutritional status at baseline†‡
Weight-for-age Z score −1·75 (1·07) −1·65 (1·09) −1·73 (1·07) −1·58 (1·07)
Height-for-age Z score −1·67 (0·98) −1·63 (1·03) −1·65 (0·99) −1·62 (1·03)
Helminth infection at follow-up
Hookworm 44/357 (12%) 45/387 (12%) 29/255 (11%) 23/192 (12%)
Ascaris lumbricoides 11/357 (3%) 21/387 (5%) 6/255 (2%) 7/192 (4%)
Trichuris trichiura 15/357 (4%) 36/387 (9%) 9/255 (4%) 17/192 (9%)
Schistosoma mansoni 28/357 (8%) 18/387 (5%) 14/255 (5%) 10/192 (5%)
Study endpoints at baseline†
Number of children examined 361 416 261 201
P falciparum prevalence 130/349 (37%) 139/406 (34%) 87/254 (34%) 72/195 (37%)
P falciparum intensity per μL in slide-positive: geometric mean 802·32 (1·19) 733·21 (1·14) 805·45 (1·11) 725·65 (1·12)
Anaemia prevalence 55/359 (15%) 44/416 (11%) 34/260 (13%) 24/201 (12%)
Mean haemoglobin concentration (g/L) 122·92 (15·26) 124·81 (13·92) 123·26 (14·57) 124·90 (14·06)
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Intention-to-treat population Per-protocol population
Placebo IPT Placebo IPT
Mean score in counting sounds test§ 11·19 (3·02) 11·25 (3·04) 11·12 (2·99) 11·08 (3·22)
Mean score in code transmission test§ 13·03 (4·99) 13·31 (4·99) 13·11 (4·74) 13·47 (5·00)
Data are mean (SD) or n/N (%) unless specified otherwise.
*
Data obtained at follow-up for education cohort recruited from classes 5 and 6 (11–16 years), except where indicated.
†
Measured at baseline.
‡
Anthropometric indices calculated on the basis of the 2000 Centers for Disease Control and Prevention growth charts. Weight-for-height
standards were only available for children up to 121 cm in height and thus not calculated. Measured at baseline (ITT: 359 placebo, 415 IPT; PP:
260 placebo, 200 IPT).
§
Sustained attention tested at baseline (ITT: 345 placebo, 364 IPT; PP: 249 placebo, 178 IPT).
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Table 3
Data on school level characteristics* for schoolchildren included in analyses of education outcomes
Placebo IPT
School exam performance in previous 3 years†‡
Lowest tertile (stratum 1) 219·55 (219·48–220·25) 205·34 (204·34–217·76)
Middle tertile (stratum 2) 246·38 (245·96–249·23) 233·47 (232·43–235·05)
Upper tertile (stratum 3) 267·81 (266·95–272·32) 291·08 (277·63–296·91)
Mean number of children enrolled per school (classes 0–7)†
School performance stratum 1 156·0 (44·20) 144·2 (50·25)
School performance stratum 2 214·6 (50·86) 250·8 (33·80)
School performance stratum 3 298·8 (161·06) 338·2 (124·12)
Quality of social science teaching during final term of intervention
Teacher absenteeism
Absent for >1 day 11 (73%) 10 (67%)
Number of days absent 3 days (2–8) 3·5 days (2–5)
Proportion of work completed and marked 0·16 (0·15) 0·14 (0·17)
Progression: number of lessons per week 4·25 (1·83) 6·33 (3·90)
Lesson plans: number of lesson plans per week 3·53 (2·83) 3·67 (3·29)
Number of teaching aids in use
None 4 (27%) 5 (33%)
One 1 (7%) 2 (13%)
Two or more 10 (67%) 8 (53%)
Data are mean (SD), median (IQR), or n (%).
*
Intention-to-treat and per-protocol populations drawn from same set of 30 study schools (15 placebo, 15 IPT).
†
Five schools per strata in each treatment arm.
‡
Median (IQR) of the mean pass rate in national primary school leaving exams (KCPE) during 3 years before intervention.
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Table 4
Effect of IPT on health outcomes: anaemia, haemoglobin, and P falciparum parasitaemia
Placebo IPT p value Risk ratio/mean
difference*(95%
CI)
Number of children Outcome Number of children Outcome
Intention-to-treat analysis†
Prevalence of anaemia
Crude‡ 2302 12·6% 2604 6·3% p=0·041 0·50 (0·26–0·97)
(Range between schools; k=0·44) (5·7–40·3%) (0·7–12·5%)
Observed/expected: adjusted for
strata§
2302 1·347 2604 0·689 p=0·034 0·51 (0·28–0·95)
Observed/expected: fully adjusted¶ 2292 1·326 2599 0·689 p=0·028 0·52 (0·29–0·92)
Mean haemoglobin concentration (g/L)
Crude‡ 2302 124·5 2604 130·1 p=0·002 5·62 (2·19–9·05)
(Range between schools; k=0·03) (111·9–128·3) (123·7–138·4)
Observed–expected: adjusted for
strata§
2302 −2·94 2604 2·68 p=0·002 5·62 (2·19–9·05)
Observed–expected: fully adjusted¶ 2292 −2·14 2599 2·88 p=0·005 5·01 (1·62–8·41)
Prevalence of P falciparum infection
Crude‡ 2294 39·7% 2584 4·6% p<0·0001 0·12 (0·05–0·27)
(Range between schools; k=0·14) (26·2–58·1%) (0·8–14·1%)
Observed/expected: adjusted for
strata§
2294 1·949 2584 0·226 p<0·0001 0·12 (0·05–0·27)
Observed/expected: fully adjusted‖ 1938 2·532 2182 0·286 p=0·0002 0·11 (0·05–0·27)
Intensity of P falciparum infection (per μL)**
Crude‡ 890 1282·5 104 2118·8 p=0·255 1·65 (0·68–4·01)
Observed–expected: adjusted for
strata§
890 −0·254 104 0·248 p=0·255 1·65 (0·68–4·01)
Observed–expected: fully adjusted‖ 699 0·315 74 1·013 p=0·108 2·01 (0·85–4·77)
Per-protocol analysis††
Prevalence of anaemia
Crude‡ 1392 12·8% 1070 5·7% p=0·027 0·44 (0·22–0·90)
(Range between schools; k=0·44) (5·5–36·4%) (0–17·9%)
Observed/expected: adjusted for
strata§
1392 1·369 1070 0·624 p=0·027 0·46 (0·23–0·91)
Observed/expected: fully adjusted¶ 1387 1·351 1068 0·633 p=0·025 0·47 (0·24–0·90)
Mean haemoglobin concentration (g/L)
Crude‡ 1392 124·8 1070 130·7 p=0·0010 5·99 (2·70–9·28)
(Range between schools; k=0·03) (114·9–128·5) (123·2–139·2)
Observed–expected: adjusted for
strata§
1392 −2·90 1070 3·09 p=0·0010 5·99 (2·70–9·28)
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Placebo IPT p value Risk ratio/mean
difference*(95%
CI)
Number of children Outcome Number of children Outcome
Observed–expected: fully adjusted¶ 1387 −2·32 1068 3·17 p=0·0023 5·49 (2·16–8·81)
Prevalence of P falciparum infection
Crude‡ 1386 39·3% 1059 3·7% p=0·0002 0·10 (0·03–0·28)
(Range between schools; k=0·18) (23·0–59·4%) (0–13·3%)
Observed/expected: adjusted for
strata§
1386 1·709 1059 0·166 p=0·0003 0·10 (0·03–0·30)
Observed/expected: fully adjusted‖ 1228 2·064 957 0·189 p=0·0003 0·09 (0·03–0·29)
Intensity of P falciparum infection (per μL)**
Crude‡ 530 1110·5 38 1262·2 p=0·799 1·14 (0·41–3·18)
Observed–expected: adjusted for
strata§
530 −0·251 38 −0·123 p=0·799 1·14 (0·41–3·18)
Observed–expected: fully adjusted‖ 444 0·101 32 0·210 p=0·829 1·12 (0·40–3·12)
Placebo and IPT intervention arms both contained 15 schools.
*
Risk ratios are presented for binary outcomes (anaemia and P falciparum occurrence), mean differences are presented for haemoglobin
concentrations. Ratio of geometric means are presented for P falciparum intensity among those infected.
†
Intention-to-treat analysis: placebo n=2305, range 64–382 children per school; IPT n=2611, range 70–341 children per school.
‡
Crude estimates account for the cluster-randomised trial design. Prevalence was calculated for each school, and the percentage shown represents
the mean of these cluster-specific prevalence values.
§
Adjusted for stratified, cluster-randomised, trial design.
¶
Fully adjusted for trial design, age, sex, age/sex interaction, and nutritional status. All covariates measured at follow-up.
‖
Fully adjusted for trial design, age, sex, age/sex interaction, bednet use, and migration history. All covariates measured at follow-up.
**
Geometric mean parasite density calculated in parasite-positive children only.
††
Per-protocol analysis: placebo n=1394, range 33–171 children per school. IPT n=1070, range 24–165 children per school.
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Table 5
Effect of IPT on cognition: attention in class
Placebo IPT p value Difference in
means (95% CI)
Number of
children
tested
Mean score Number of
children
tested
Mean score
Intention-to-treat analysis
Counting sounds (maximum score 20)*
Crude† 378 15·41 433 16·01 p=0·048 0·60 (0·01 to
1·19)
(Range between schools; k=0·03) (13·47–16·40) (14·63–17·30)
Observed–expected: adjusted for strata‡ 378 −0·329 433 0·266 p=0·048 0·60 (0·01 to
1·19)
Observed–expected: fully adjusted§ 328 1·405 351 3·208 p=0·030 1·80 (0·19 to
3·41)
Code transmission (maximum score 40)¶
Crude† 368 23·28 423 27·20 p=0·019 3·92 (0·70 to
7·14)
(Range between schools; k=0·15) (16·87–31·00) (19·50–33·62)
Observed–expected: adjusted for strata‡ 368 −1·862 423 2·058 p=0·019 3·92 (0·70 to
7·14)
Observed–expected: fully adjusted§ 323 0·572 342 6·624 p=0·0007 6·05 (2·83 to
9·27)
Teacher-rated score for inattentive or hyperactive-compulsive behaviours (maximum score 38)‖
Crude† 137 11·67 126 10·90 p=0·543 −0·77 (−3·36 to
1·82)
Observed–expected: adjusted for strata‡ 137 0·170 126 −0·729 p=0·481 −0·90 (−3·49 to
1·69)
Observed–expected: fully adjusted** 134 0·204 120 0·057 p=0·910 −0·15 (−2·81 to
2·52)
Per-protocol analysis
Counting sounds (maximum score 20)*
Crude† 272 15·48 209 16·14 p=0·097 0·66 (−0·13 to
1·45)
(Range between schools; k=0·02) (13·14–16·33) (13·00–17·70)
Observed–expected: adjusted for strata‡ 272 −0·255 209 0·407 p=0·097 0·66 (−0·13 to
1·45)
Observed–expected: fully adjusted§ 238 1·403 173 3·530 p=0·068 2·13 (−0·17 to
4·42)
Code transmission (maximum score 40)¶
Crude† 264 23·32 205 27·72 p=0·013 4·40 (1·01 to
7·80)
(Range between schools; k=0·16) (15·60–31·20) (17·86–33·40)
Observed–expected: adjusted for strata‡ 264 −2·155 205 2·249 p=0·013 4·40 (1·01 to
7·80)
Observed–expected: fully adjusted§ 234 0·471 169 7·214 p=0·0016 6·74 (2·84 to
10·65)
Teacher-rated score for inattentive or hyperactive-compulsive behaviours (maximum score 38)‖
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Placebo IPT p value Difference in
means (95% CI)
Number of
children
tested
Mean score Number of
children
tested
Mean score
Crude† 106 11·58 68 10·62 p=0·537 −0·96 (−4·11 to
2·19)
Observed–expected: adjusted for strata‡ 106 −0·135 68 −1·499 p=0·381 −1·36 (−4·52 to
1·79)
Observed–expected: fully adjusted** 105 −0·019 67 −0·457 p=0·818 −0·44 (−4·33 to
3·45)
Placebo and IPT intervention arms both contained 15 schools.
*
Test included 20 counting sounds tasks, with up to 30 sounds per task. The total score was the number of times the sounds were counted correctly.
†
Crude estimates account for the cluster-randomised trial design.
‡
Adjusted for stratified, cluster-randomised, trial design.
§
Fully adjusted for strata, age, sex, class, baseline haemoglobin concentration, and sustained attention score at baseline. Baseline haemoglobin
concentration and baseline sustained attention scores were not available for all children.
¶
Test included two tests, in which children were required to record the two or three numbers, respectively, that preceded the code. Each test
comprised 20 sets of code transmission targets. The total score was the number of times the target digits were correctly identified.
‖
Data available for children in 14 schools in each treatment arm in per-protocol analysis; and for 14 schools in placebo arm in intention-to-treat
analysis.
**
Fully adjusted for strata, age, sex, class, baseline haemoglobin concentrations. Baseline haemoglobin was not available for all children. Since
attention function was only assessed post-treatment, no adjustments could be made for attention at baseline.
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Table 6
Effect of IPT on educational achievement
Placebo IPT p value Difference in
means (95% CI)
Number of
children
tested
Mean score Number of
children
tested
Mean score
Intention-to-treat analysis
Social science exam: standard 6 (maximum score 39)*
Crude† 240 16·20 263 16·27 p=0·951 0·07 (−2·36 to
2·50)
Observed–expected: adjusted for strata‡ 240 −0·002 263 0·071 p=0·951 0·07 (−2·36 to
2·50)
Observed–expected: fully adjusted§ 200 1·893 250 1·440 p=0·747 −0·45 (−3·32 to
2·41)
Social science exam: standard 7 (maximum score 34)*¶
Crude† 198 14·78 232 15·60 p=0·305 0·83 (−0·80 to
2·46)
Observed–expected: adjusted for strata‡ 198 −0·399 232 0·380 p=0·333 0·78 (−0·85 to
2·41)
Observed–expected: fully adjusted§ 137 3·815 195 3·964 p=0·938 0·15 (−3·75 to
4·05)
Per-protocol analysis
Social science exam: standard 6 (maximum score 39)*
Crude† 167 16·26 119 16·66 p=0·774 0·40 (−2·46 to
3·26)
Observed–expected: adjusted for strata‡ 167 −0·419 119 −0·017 p=0·774 0·40 (−2·46 to
3·26)
Observed–expected: fully adjusted§ 144 1·583 116 1·193 p=0·784 −0·39 (−3·29 to
2·51)
Social science exam: standard 7 (maximum score 34)*¶
Crude† 146 14·71 120 15·41 p=0·362 0·71 (−0·87 to
2·28)
Observed–expected: adjusted for strata‡ 146 −0·606 120 0·018 p=0·421 0·62 (−0·95 to
2·20)
Observed–expected: fully adjusted§ 105 3·856 103 3·512 p=0·867 −0·34 (−4·53 to
3·84)
Placebo and IPT intervention arms both contained 15 schools.
*
Total number of correctly answered questions in a multiple-choice exam, specific to curriculum taught in each year group.
†
Crude estimates account for the cluster-randomised trial design.
‡
Adjusted for stratified, cluster-randomised, trial design.
§
Fully adjusted for strata, age, sex, teacher absenteeism, quality of schooling, and baseline haemoglobin concentration. Baseline haemoglobin
concentration was not available for all children. Social science exams were not carried out at baseline.
¶
Data available for children in 14 schools in the placebo arm.
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